Nova Patents
PL373398A1

Heterocyclicsulfonamide hepatitis c virus inhibitors

Abstract

The present invention relates to tripeptide compounds, compositions containing such compounds and methods for using such compounds for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.

Term

Term ended

Projected expiry passed 20 May 2023, 3.3 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

19 members in 11 offices

This recordMember, by publication datePriority claim1 more office is in the list below

Priority claims4

Priority claims
DocumentOfficeKindDate
38210402United States of AmericaP
38210402United States of AmericaP
0260382104–––
US20020382104P–––

Members19

Family members, oldest first
DocumentOfficeKind
WO03099316A1World Intellectual Property Organization (WIPO)A1
AU2003248535A1AustraliaA1
US2004072761A1United States of AmericaA1
IS7532AIcelandA
NO20044808LNorwayL
EP1506000A1European Patent Office (EPO)A1
US6869964B2United States of AmericaB2
EP1506000A4European Patent Office (EPO)A4
PL373398A1This recordPolandA1
JP2005526144AJapanA
JP4312711B2JapanB2
EP1506000B1European Patent Office (EPO)B1
AT481106TAustriaT
ATE481106T1AustriaT1
DE60334205D1GermanyD1
ES2350201T3SpainT3
EP1506000B9European Patent Office (EPO)B9
ES2350201T9SpainT9
PL211889B1PolandB1